ArticleJournal of pain research2026
Metabolomic Insights into Reprogrammed Caffeine Metabolism in the Hippocampus of Myofascial Pain Syndrome Rats.
Article in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The objective of this investigation was to examine the histopathological alterations in the rat hippocampus induced by myofascial trigger points (MTrPs), assess hippocampal neuronal excitability by measuring c-fos protein expression, and Non-targeted metabolomics was employed to profile hippocampal metabolite variations and elucidate the pathophysiological mechanisms underlying myofascial pain syndrome (MPS). Methods: Male SD rats were divided into MTrPs group (n=6) and control group (n=6). The MTrPs model was induced through localized blunt impact to the gastrocnemius muscle followed by repetitive eccentric exercise. Successful modeling was confirmed by the presence of palpable taut bands (TBs), along with measurements of mechanical and thermal withdrawal thresholds (MWT and TWL), and electromyographic (EMG) recordings. We assessed hippocampal neuropathological damage using HE and Nissl staining and measured c-fos protein expression to reflect hippocampal neuronal activity. Metabolomics analysis with statistical variable analysis helped distinguish affected individuals from controls. Results: TB detection, MWT, TWL and EMG confirmed successful model establishment. Pathological evaluation indicated a disorganized structure and neuronal injury in the CA1 region of the hippocampus in MTrPs rats, alongside elevated c-fos protein expression, suggesting heightened neuronal excitation and potential central sensitization. Metabolomic profiling revealed 79 differentially expressed metabolites (VIP > 1, P < 0.05) in MPS rats compared with controls. Further KEGG enrichment analysis demonstrated that 26 of these metabolites were involved in 20 metabolic pathways, with caffeine metabolism being notably affected ( Conclusion: MPS causes pathological damage to the hippocampus, and increased c-fos protein expression suggests possible central sensitization in MPS rats. Metabolomics analysis revealed significant hippocampal changes, particularly reduced caffeine metabolism, underscoring potential central mechanisms in MPS. This study enhances our understanding of MPS etiology based on hippocampal pathology and provides potential biological markers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.